// App-Quantinova.ai

FRI0307 : Changes in Urinary Biomarker Levels Can Predict Treatment Responses in Lupus Nephritis

Researchers

Presenter

  • J. Wither

Principal Investigators

  • S. Prokopec

  • B. Noamani

  • D. Bonilla

  • Z. Touma

  • C. Avila-Casado

  • H. Reich

  • J. Scholey

  • P. Boutros

  • P. Fortin

  • C. Landolt-Marticorena

Medical Centers

  • CHU de Quebec - Universite Laval, Quebec City, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Nephrology

Disease

  • Lupus nephritis

Biomarkers

  • Adiponectin

  • C-C Motif Chemokine Ligand 2

  • Plasminogen activator ihnibitor-1

  • Platelet Factor 4

  • Clusterin

  • Cystatin C

  • Granulocyte-macrophage-colony stimulating factor

  • Interleukin 6

  • Interleukin-15

  • Lipocalin 2

  • Matrilysin

  • Soluble Vascular Cell Adhesion Molecule-1

  • TIMP Metallopeptidase Inhibitor 1

Drug/Treatment

  • GM-CSF

  • IL-15

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved